Both in Lab Analytical Instruments
Astrotech Corporation (DE) vs Harvard Bioscience
Over the past year ASTC returned +32.6% and HBIO returned +110.6%; their daily moves had a correlation of -0.00.
ASTC +32.6% HBIO +110.6%Growth of $1, one year, split-adjusted
| Metric | ASTC | HBIO |
|---|---|---|
| Price | $5.27 | $8.42 |
| Market cap | $11.1M | $38.3M |
| Today | +0.67% | +0.84% |
| 1 month | −30.0% | +5.8% |
| 6 months | +52.2% | +37.4% |
| Year to date | +52.2% | +25.9% |
| 1 year | +23.9% | +109.5% |
| Revenue growth (YoY) | −42.7% | +11.1% |
| Gross margin | −35.7% | 55.6% |
| Net margin | −2592.1% | −12.8% |
| P/E (TTM) | — | — |
| Price / sales | 12.1× | 0.4× |
| Net cash | $11.3M | -$30.2M |
| Dividend yield | — | — |
| Volatility (60d) | 82.1% | 36.2% |
| Short % of float | 3.3% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).